Literature DB >> 7738566

Molecular diagnostic analysis for Huntington's disease: a prospective evaluation.

J C MacMillan1, P Davies, P S Harper.   

Abstract

The availability of mutation analysis for the CAG repeat expansion associated with Huntington's disease has prompted clinicians in various specialties to request testing of samples from patients displaying clinical features that might be attributable to Huntington's disease. A series of 38 cases presenting with clinical features thought possibly to be due to Huntington's disease were analysed prospectively. In 53% of such cases presenting initially with chorea and 62.5% with psychiatric symptoms an expansion was identified, a considerable lower proportion than found in previous series where the diagnosis was considered definite on clinical and genetic grounds. Mutation analysis is likely to be of considerable value in the diagnosis of Huntington's disease, especially where the family history in previous generations is inadequate or apparently negative.

Entities:  

Mesh:

Year:  1995        PMID: 7738566      PMCID: PMC1073445          DOI: 10.1136/jnnp.58.4.496

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Megadose corticosteroids in multiple sclerosis.

Authors:  M J Kupersmith; D Kaufman; D W Paty; G Ebers; H McFarland; K Johnson; S Reingold; J Whitaker
Journal:  Neurology       Date:  1994-01       Impact factor: 9.910

2.  Expanded CAG trinucleotide repeat of Huntington's disease gene in a patient with schizophrenia and normal striatal histology.

Authors:  D St Clair
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

3.  Molecular analysis and clinical correlations of the Huntington's disease mutation.

Authors:  J C MacMillan; R G Snell; A Tyler; G D Houlihan; I Fenton; J P Cheadle; L P Lazarou; D J Shaw; P S Harper
Journal:  Lancet       Date:  1993-10-16       Impact factor: 79.321

4.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

5.  Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.

Authors:  R G Snell; J C MacMillan; J P Cheadle; I Fenton; L P Lazarou; P Davies; M E MacDonald; J F Gusella; P S Harper; D J Shaw
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

6.  Trinucleotide repeat length instability and age of onset in Huntington's disease.

Authors:  M Duyao; C Ambrose; R Myers; A Novelletto; F Persichetti; M Frontali; S Folstein; C Ross; M Franz; M Abbott
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Huntington disease without CAG expansion: phenocopies or errors in assignment?

Authors:  S E Andrew; Y P Goldberg; B Kremer; F Squitieri; J Theilmann; J Zeisler; H Telenius; S Adam; E Almquist; M Anvret
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

8.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

Authors:  A Tyler; D Ball; D Craufurd
Journal:  BMJ       Date:  1992-06-20

9.  Proceed with care: direct predictive testing for Huntington disease.

Authors:  C M Benjamin; S Adam; S Wiggins; J L Theilmann; T T Copley; M Bloch; F Squitieri; W McKellin; S Cox; S A Brown
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

10.  Mutation analysis in patients with possible but apparently sporadic Huntington's disease.

Authors:  M B Davis; D Bateman; N P Quinn; C D Marsden; A E Harding
Journal:  Lancet       Date:  1994-09-10       Impact factor: 79.321

View more
  3 in total

Review 1.  Evidence from biomarkers and surrogate endpoints.

Authors:  Andrew Feigin
Journal:  NeuroRx       Date:  2004-07

2.  Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing.

Authors:  M A Ramos-Arroyo; S Moreno; A Valiente
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

Review 3.  What do we know about Late Onset Huntington's Disease?

Authors:  Sai S Chaganti; Elizabeth A McCusker; Clement T Loy
Journal:  J Huntingtons Dis       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.